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Excessive intake of saturated fatty acids (SFA) is associated 
with several disease states including cardiovascular disease, dia-
betes and certain types of cancer.1-3 While multiple processes 
are implicated, a key mechanism by which SFAs have been 
shown to drive disease is through increasing the activity of 
inflammatory pathways.
Indeed increased SFA intake has been repeatedly correlated 
with increased tissue and/or serum cytokine levels in humans.4,5 
While further research is required to confirm the processes 
involved, both direct and indirect mechanisms have been 
implicated. Indirectly SFA intake stimulates postprandial as 
well as longer term inflammation by increasing the expression 
of proinflammtory genes.6-8 Following ingestion, SFAs have 
also been found to initiate an innate immune response by both 
promoting the translocation of endotoxins such as lipopolysac-
charide (LPS) from the gut into circulation and by increasing 
the differentiation and proliferation of T helper 1 (Th1) and 
Th17 cell populations within the small intestine.9,10
In addition to these multi-step processes evidence sug-
gests that SFAs also promote inflammation directly by activat-
ing toll-like receptor (TLR) 2/4. Through this mechanism, 
SFAs are thought to drive cyclooxygenase-2 (COX-2) and 
nuclear factor kappa B (NF-κβ) mediated production of 
proinflammatory cytokines, such as TNF-α.8,11-13 However 
the direct activation of TLRs by SFA is contentious. Recent 
research suggests that while TLRs do regulate SFA induced 
inflammation,14 this may be because SFA upregulate TLRs that 
have already been primed, by LPS for example.13,14 Regardless 
of the precise mechanism involved, there is strong evidence that 
SFA ingestion upregulates innate immune activity.
Interferon gamma (IFN-γ) is a cytokine secreted by a num-
ber of innate immune cells including the Th1 subtype. Its 
mRNA levels have been shown to increase in murine models 
following chronic SFA ingestion.15 Importantly IFN-γ induces 
the transcription of indoleamine 2,3 dioxygenase (IDO), 
thereby modulating catabolism of the low abundance amino 
acid tryptophan (Trp). Induction of IDO results in reduced 
T-cell activation and proliferation, through negative feedback 
mechanisms,16 as well as an increase in the breakdown of Trp 
to kynurenine (Kyn).
Accordingly the ratio of Kyn to Trp concentrations 
([Kyn]:Trp]) has been widely utilised as an indirect meas-
ure of IDO and consequently IFN-γ mediated inflamma-
tory activity.17,18 However, despite the demonstrated 
association between SFAs and increased inflammation, the 
effect of SFA intake on [Kyn]:Trp] has not yet been 
investigated.
Saturated Fatty Acid Intake Is Associated With  
Increased Inflammation, Conversion of Kynurenine  
to Tryptophan, and Delta-9 Desaturase Activity  
in Healthy Humans
Jade Berg1, Neda Seyedsadjadi1,2 and Ross Grant1,2,3
1Australasian Research Institute, Sydney Adventist Hospital, Sydney, Australia. 2School of Medical 
Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia. 3Sydney 
Adventist Hospital Clinical School, University of Sydney, Sydney, Australia.
ABSTRACT: Saturated fat ingestion has previously been linked to increases in inflammation. However the relationship between saturated 
fatty acid (SFA) intake and the kynureine:tryptophan ratio ([Kyn]:[Trp]), a marker of inflammation, has not been previously investigated. This 
study evaluated in healthy, middle aged, individuals (men = 48, women = 52), potential relationships between SFA intake, red blood cell (RBC) 
membrane SFAs and monounsaturated fatty acids (MUFA), the [Kyn]:[Trp] ratio, C-reactive protein (CRP), TNF-α and Δ9 desaturase activity. 
[Kyn]:[Trp] was positively associated with increases in Total fat (P = .034) intake, including Total SFA (P = .029) and Total MUFA (P = .042) intakes. 
Unexpectedly the [Kyn]:[Trp] ratio was inversely associated with the percentage of Total SFA (P = .004) and positively associated with percent-
age of Total MUFA (P = .012) present in the RBC membrane. We found a positive association between Δ9 desaturase activity, responsible for 
the desaturation of a various SFAs to MUFAs, and [Kyn]:[Trp] (P = .008). [Kyn]:[Trp] was also positively associated with CRP (P = .044), however 
no significant relationship between [Kyn]:[Trp] and TNF-α was found. This study shows for the first time that SFA consumption increases inflam-
matory pathways linked to increased tryptophan to kynurenine conversion, even in healthy humans. Our data also suggests that SFA linked 
increases in inflammation occur concomitantly with an upregulation of Δ9 desaturase activity resulting in increased desaturation of SFA sub-
strates to their MUFA derivatives.
KeyWoRDS: Indoleamine 2,3 dioxygenase (IDO), tumour necrosis factor-α (TNF-α), diet, oleic acid, stearic acid
ReCeIVeD: August 4, 2020. ACCePTeD: November 25, 2020.
TyPe: Original Research
FunDIng: The author(s) received no financial support for the research, authorship and/or 
publication of this article.
DeClARATIon oF ConFlICTIng InTeReSTS: The author(s) declared no potential 
conflicts of interest with respect to the research, authorship and/or publication of this 
article.
CoRReSPonDIng AuTHoR: Ross Grant, Australasian Research Institute, Sydney 
Adventist Hospital, 185 Fox Valley Road, Wahroonga, NSW 2076, Australia.  Email: ross.
grant@sah.org.au
981946 TRY0010.1177/1178646920981946International Journal of Tryptophan ResearchBerg et al
research-article2020
2 International Journal of Tryptophan Research 
To better understand this relationship we therefore explored, 
in an essentially healthy cohort, potential relationships between; 
the plasma [Kyn]:[Trp] ratio and fatty acid (FA) intake, RBC 
membrane FA levels and Δ9 desaturase activity (a key player in 
human cell membrane lipid metabolism). We also measured 
plasma C-reactive protein (CRP) and TNF-α concentrations 
as additional markers of inflammation.
Methods
Participants
This cross-sectional study included 100 participants (48 males 
and 52 females) aged between 40 and 75 years. Participant 
recruitment was conducted at the Sydney Adventist hospital, 
and the University of New South Wales, Sydney, via advertise-
ments on the hospital/university intranet. Participant mean 
BMI, visceral fat mass and blood pressure are presented in 
Table 1. Participants were in general good health, non-
smokers, and did not have a known microbial infection, suffer 
from any form of neurodegenerative disease, medically diag-
nosed liver or kidney disorder, or inflammatory bowel disease. 
Participants had not been diagnosed with cancer or treated for 
cancer and had not undergone major surgery in the past 2 years. 
In the 2 weeks prior to testing participants had not taken anti-
biotics, illicit drugs, supplements or any complementary med-
icines and where not currently taking any diabetic, thyroid 
or anti-inflammatory medications. After obtaining written 
informed consent, participants were asked to complete a 
dietary questionnaire to assess their fatty acid intake. Blood 
was performed in a fasted state (about 12 hours) on the same 
day as the completion of the questionnaire. Ethical approval 
for the study was obtained from the Adventist HealthCare 
Limited Human Research Ethics Committee, Sydney Adventist 
Hospital, Australia (HREC number: 2013-022).
Plasma high sensitivity C-reactive protein (CRP) 
and tumour necrosis factor-α (TNF-α)
Plasma high sensitivity C-reactive protein (CRP) levels were 
quantified using a immunoturbidimetric assay on a Roche/
Hitachi Cobas C system (Sydney Adventist Hospital, pathol-
ogy laboratory). Plasma tumour necrosis factor-α (TNF-α) 
was measured using the MILLIPLEX® MAP human high-
sensitivity T-cell magnetic bead panel immunoassay (Merck 
KGaA, Darmstadt, Germany).
Plasma kynurenine and tryptophan
Plasma kynurenine (Kyn) and tryptophan (Trp) levels 
were measured by high-performance liquid chromatography 
(Shimadzu LC-10AVP system, equipped with SPD-10A UV 
detector, Kyoto, Japan), as previously described.19 The 
[Kyn]:[Trp] ratio was calculated by dividing the concentration 
of Kyn by the concentration of Trp.
Fatty acid (FA) intake
Self-report average daily fatty acid intake (g/day) was assessed 
using the Cancer Council Victoria Dietary Questionnaire for 
Epidemiological Studies Version 2 (DQES v2). This question-
naire asks participants to report their usual consumption of 74 
foods and 6 alcoholic beverages over the preceding 12 months 
using a 10-point frequency scale. Additional questions are 
included about the type, number and serving size of fruit, veg-
etables, bread, dairy products, eggs, fat spreads and sugar. Fatty 
acid intakes were computed from NUTTAB 2010 and 
AUSNUT 2007, national government food composition data-
bases, using software developed by the Cancer Council of 
Victoria. However the intake of Vaccenic acid could not be 
quantified. Both the development of the DQES and its valida-
tion in Australian adults have been previously reported.20
RBC membrane fatty acids
The fatty acid composition of red blood cells (RBC) was deter-
mined using a modified method originally developed by 
Lepage and Roy (1986).21 Briefly sample fatty acids were 
methylated by the addition of 200 μl of acetyl chloride fol-
lowed by heating at 100°C for 1 hour. About 5 ml of 6% K2CO3 
solution was added to stop the reaction. The samples were then 
centrifuged at 3000 × g for 10 minutes and the supernatant 
containing the fatty acid methyl esters was transferred into 
glass vials. Fatty acid methyl esters were quantified using a 
Hewlett Packard 6890 Gas Chromatograph equipped with a 
Table 1. Participant age and physiological parameters.
MAlE (N = 48) FEMAlE (N = 52)
 MEAN SD MEAN SD
Age (years) 57 9 55 8
BMI (kg/m2) 26.3 4.0 26.2 5.1
Visceral adipose tissue mass (g) 1486 1177 672 610
Systolic blood pressure (mmHg) 129 13 124 16
Diastolic blood pressure (mmHg) 78 9 79 10
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flame ionisation detector. The identity of each fatty acid peak 
in the sample was determined by comparing the peaks reten-
tion time with the retention time of synthetic standards of 
known fatty acid composition. Fatty acid results are reported as 
percentage of total fatty acids.
Δ9 Desaturase (Δ9) activity
Δ9 Desaturase (Δ9) activity was estimated by calculating the 
ratio of membrane Oleic acid (C18:1(n-9)) to membrane 
Stearic acid (C18:0).
Statistical analysis
Biochemical and dietary intake data were integrated using 
SPSS version 25.0 for Windows. Outliers classified as 
3 ± standard deviations from the mean were removed. 
Normality was assessed using both the Shapiro-Wilk and 
Kolmogorov-Smirnov tests. Histogram displays were also visu-
alised. When required Box-Cox or log transformations were 
performed. Multiple linear regression controlling for age and 
gender was undertaken to assess associations between the 
[Kyn]/[Trp] ratio, CRP, TNF-α, the percentage of RBC mem-
brane fatty acids and fatty acid intake. Normality of the stand-
ardised residuals was assessed by examining histograms and 
P-P plots. Scatter plots of the residuals were also assessed to 
confirm homoscedasticity. All Tolerance values were greater 
than 0.01 and all Variance Inflation Factors (VIF) were less 
than 10. R-squared (R2) values and standardised coefficients 
(β) are provided throughout. Pearson’s correlation was used to 
determine associations between individual fatty acids, both 
membrane and diet derived. The r value is provided. 
Associations were considered significant when P ⩽ .05.
Results
Relationships between plasma [Kyn]:[Trp] ratio 
and FA intake
Mean levels of kynurenine, tryptophan, the [Kyn]:[Trp] ratio 
and daily intake of fatty acids are presented in Table 2. We 
observed a significant positive association between the 
[Kyn]:[Trp] ratio and Total fat intake (n = 98, R2 = 0.152, 
β = 0.210, P = .034) including Total MUFA (n = 98, R2 = 0.148, 
β = 0.199, P = .042) and Total SFA (n = 98, R2 = 0.154, β = 0.218, 
P = .029).
Although not significant, an increase in the [Kyn]:[Trp] 
ratio also tended to be related to an increased intake of both 
Palmitic (n = 98, R2 = 0.140, β = 0.179, P = .073), Stearic (n = 98, 
R2 = 0.143, β = 0.188, P = .059) as well as Arachidic (n = 98, 
R2 = 0.134, β = 0.159, P = .110) saturated fats.
An increased intake of Oleic acid also tended to be associ-
ated with an increase in the [Kyn]:[Trp] ratio, although this 
was not statistically significant (n = 96, R2 = 0.137, β = 0.171, 
P = .089). No association between the [Kyn]:[Trp] ratio and the 
intake of Palmitoleic (n = 96, R2 = 0.114, β = 0.066, P = .505) or 
Gondoic (n = 97, R2 = 0.107, β = 0.045, P = .657) MUFAs were 
observed. The intake of Vaccenic acid was not quantified.
Relationship between plasma [Kyn]:[Trp] ratio 
and RBC membrane FA levels
Unexpectedly we observed a significant inverse association 
between the [Kyn]:[Trp] ratio and the percentage of Total SFA 
incorporated into the RBC membrane (n = 98, R2 = 0.186, 
β = −0.286, P = .004). In particular an increase in the [Kyn]:[Trp] 
ratio was found to be significantly associated with a reduction 
in the percentage of Stearic acid in the cell membrane (n = 98, 
R2 = 0.158, β = −0.224, P = .023) and a non-significant reduction 
in the percentage Palmitic (n = 98, R2 = 0.123, β = −0.116, 
P = .240) as well as Arachidic acid (n = 98, R2 = 0.120, β = −0.102, 
P = .296).
We also observed a positive association between the 
[Kyn]:[Trp] ratio and the percentage of Total MUFAs incor-
porated into the membrane (n = 98, R2 = 0.168, β = 0.243, 
P = .012). Specifically a significant positive association between 
the [Kyn]:[Trp] ratio and the membrane percentage of 
Palmitoleic (n = 98, R2 = 0.164, β = 0.237, P = .015) as well as 
Oleic acid (n = 98, R2 = 0.161, β = 0.227, P = .019) was observed. 
No associations between the [Kyn]:[Trp] ratio and the per-
centage of Vaccenic (n = 98, R2 = 0.112, β = 0.05, P = .623) or 
Gondoic (n = 97, R2 = 0.113, β = −0.059, P = .551) acid was 
found. The mean membrane percentages of FAs are presented 
in Table 2.
Correlation between dietary FA intake and RBC 
membrane FA levels
Of some surprise the dietary intake of Palmitic acid was not 
correlated with the percentage of membrane Palmitic (n = 100, 
r = 0.006, P = .952) or Palmitoleic acid (n = 100, r = −0.003, 
P = .980). An increase in Palmitic acid tended to be linked to a 
decrease in Vaccenic acid (n = 100, r = −0.145, P = .115) however 
this was not statistically significant.
While the intake of Stearic acid was not correlated with the 
percentage of membrane Stearic acid (n = 100, r = −0.049, 
P = .626), a significant positive correlation between the intake 
of Stearic acid and the percentage of Oleic acid in the mem-
brane was noted (n = 100, r = 0.203, P = .043). No correlation 
between Stearic acid intake and membrane Gondoic acid was 
observed, although the trend appeared to be inverse (n = 100, 
r = −0.066, P = .515).
The intake of Arachidic acid did not correlate with the per-
centage of Arachidic acid within the membrane (n = 100, 
r = 0.095, P = .348). Likewise the intake of Palmitoleic (n = 98, 
r = 0.032, P = .755), Oleic (n = 98, r = 0.126, P = .218) and 
Gondoic acid (n = 99, r = −0.025, P = .803) did not correlate 
with the corresponding percentage of FAs in the membrane.
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Correlation between dietary intake of total SFA 
and MUFA
We found that the intake of total SFAs significantly influenced 
the intake of MUFAs (n = 100, R2 = 0.753, β = 0.886, P = .000). 
A 1 g/day increase in SFA intake was linked to a 0.886 g/day 
increase in MUFA intake.
Correlations between individual RBC membrane 
FA levels
We then sought to determine the relationship between RBC 
membrane SFAs and their MUFA derivatives. An increase in 
the percentage of Palmitic acid within the membrane was sig-
nificantly correlated with an increase in Palmitoleic (n = 100, 
Table 2. Statistical analysis results for RBC and dietary fatty acids, kynurenine, tryptophan and independent inflammatory markers.




 Kynurenine (μmol/l) 1.06 0.22 - - -
 Tryptophan (μmol/l) 46.06 7.43 - - -
 [Kyn]:[Trp] Ratio 0.022 0.005 - - -
Independent inflammatory markers
 C-Reactive Protein (mg/l) 1.28 1.1 0.203 .044* 91
 TNF-α (pg/ml) 8.21 2.53 0.118 .243 97
RBC fatty acids  
 Palmitic acid (C16:0; %w/w) 23.6 1.3 −0.116 .240 98
 Stearic acid (C18:0; %w/w) 15.8 2.2 −0.224 .023* 98
 Arachidic acid (C20:0; %w/w) 0.3 0.1 −0.102 .296 98
 Total SFA (%w/w) 39.7 2.4 −0.286 .004* 98
 Palmitoleic acid (C16:1(n-7); %w/w) 0.8 0.5 0.237 .015* 98
 Oleic acid (C18:1(n-9); %w/w) 16.9 2.1 0.227 .019* 98
 Gondoic acid (C20:1(n-9); %w/w) 0.3 0.1 −0.059 .551 97
 Vaccenic acid (C18:1(n-7); %w/w) 1.4 0.2 0.050 .623 98
 Total MUFA (%w/w) 19.3 2.4 0.243 .012* 98
 Δ9 Desaturase Activity (units) 1.10 0.27 0.282 .008* 97
Daily fatty acid intake
 Palmitic acid (C16:0; g/day) 16.5 8.1 0.179 .073 98
 Stearic acid (C18:0; g/day) 8.4 4.8 0.188 .059 98
 Arachidic acid (C20:0; g/day) 0.3 0.07 −0.102 .296 98
 Total SFA (g/day) 28.5 13.1 0.218 .029* 98
 Palmitoleic acid (C16:1(n-7); g/day) 1.8 0.8 0.066 .505 96
 Oleic acid (C18:1(n-9); g/day) 26.7 11.2 0.171 .089 96
 Gondoic acid (C20:1(n-9); g/day) 0.3 0.2 0.045 .657 97
 ƗVaccenic acid (C18:1(n-7); g/day) - - - - -
 Total MUFA (g/day) 27.3 12.1 0.199 .042* 98
 Total All Fat (g/day) 74.0 31.0 0.210 .034* 98
ƗThe daily intake of vaccenic acid was not quantified.
*Significant associations observed between the [Kyn]:[Trp] ratio and the indicated inflammatory marker, RBC fatty acid or fatty acid intake.
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r = 0.472, P = .000) but not Vaccenic acid (n = 100, r = 0.029, 
P = .777).
While increased cell membrane levels of Stearic acid were 
correlated with a significant decrease in the percentage of its 
derivative Oleic acid (n = 100, r = −0.572, P = .000), a positive 
correlation between the percentage of Stearic acid and Gondoic 
acid was observed (n = 100, r = 0.482, P = .000).
MUFA derivatives of Arachidic acid were not quantified.
Association between Δ9 desaturase activity, the 
[Kyn]:[Trp] ratio and other markers
To further understand the relationship between membrane 
fatty acid levels and the [Kyn]:[Trp] ratio we estimated Δ9 
desaturase (Δ9) activity by calculating the ratio of product 
(membrane Oleic acid; C18:1(n-9)) to substrate (membrane 
Stearic acid; C18:0). Using this method we observed a signifi-
cant positive association between Δ9 desaturase activity and the 
[Kyn]:[Trp] ratio (n = 97, R2 = 0.096, β = 0.282, P = .008). An 
increase in Δ9 activity also tended to be associated with an 
increase in [TNF-α] (n = 99, R2 = 0.052, β = 0.177, P = .090), 
however this was not statistically significant. Δ9 desaturase 
activity was not associated with [CRP] or the intake of Total 
fats, including Total MUFA and Total SFA intake.
Relationship between inflammatory markers and 
the [Kyn]:[Tryp], FA intake and RBC membrane 
percentages
We observed a significant positive association between concen-
trations of the acute phase, inflammatory marker CRP and the 
[Kyn]:[Trp] ratio (n = 91, R2 = 0.168, β = 0.203, P = .044). While 
TNF-α levels tended to rise alongside the [Kyn]:[Trp] ratio 
this was not statistically significant (n = 97, R2 = 0.124, β = 0.118, 
P = .243).
A significant positive association was also observed between 
plasma [CRP] and the percentage of membrane Palmitic 
(n = 93, R2 = 0.078, β = 0.256, P = .015) and Palmitoleic acid 
(n = 93, R2 = 0.098, β = 0.296, P = .005) as well as Total MUFAs 
(n = 93, R2 = 0.061, β = 0.217, P = .039). No associations between 
[CRP] and the percentage of membrane Stearic, Arachidic, 
Oleic or Gonodoic acid or Total SFAs were found.
CRP was not associated with the intake of Total fats, 
including Total MUFA and Total SFA. Similarly the intake of 
Palmitic, Stearic and Arachidic acid as well as Palmitoleic, 
Oleic or Gonodoic acid were not associated with CRP 
concentrations.
No significant associations were observed between plasma 
[TNF-α] and FA intake or membrane percentages. Mean lev-
els of inflammatory markers are presented in Table 2.
Discussion
Substantial evidence has accumulated in recent years indicating 
that the ingestion of SFA increases innate immune activity 
resulting in both a postprandial and, with regular intake, 
chronic rise in pro-inflammatory mediators; see Zhou et al for 
a recent review.22 Despite this, the association between the 
ingestion of SFA and the [Kyn]:[Trp] ratio, a marker of INF-γ 
mediated inflammatory processes, had not been previously 
reported. We therefore investigated, in an essentially healthy 
cohort, whether the intake of fatty acids and their percentage 
within the membrane influence the ratio of Kyn to Trp in 
plasma.
As expected we observed a significant positive association 
between the [Kyn]:[Trp] ratio and Total fat intake, including 
total SFA intake. Looking at individual fatty acids we noted 
that, although not statistically significant, an increase in the 
intake of Palmitic, Stearic as well as Arachidic saturated fats 
tended to correspond to a rise in [Kyn]:[Trp]. As previously dis-
cussed SFA ingestion has been shown to increase the activity 
and/or concentration of pro-inflammatory mediators via activa-
tion of innate immune pathways. Specifically the consumption 
of a high fat diet, rich in SFAs, has been shown in murine mod-
els to increase the gene expression and concentration of INF-γ, 
resulting in the upregulation of IDO.23 As IDO is the rate-
limiting enzyme responsible for catabolism of Trp to Kyn, 
increased IDO activity in response to SFA induced inflamma-
tion is consistent with our findings. This is further evidenced by 
the positive association we observed between the acute phase 
inflammatory marker CRP and both the [Kyn]:[Trp] ratio and 
the saturated fat, Palmitic acid in the RBC membrane.
When looking at the relationship between the [Kyn]:[Trp] 
ratio and MUFA intake we were surprised to observe a positive 
association. This was unexpected as MUFA intake have been 
repeatedly shown to reduce inflammatory activity through 
multiple pathways.24-27 Taking this previous evidence into 
account, and noting the significant co-consumption of MUFAs 
with SFAs by participants in this study (see results above), the 
positive association observed between the [Kyn]:[Trp] ratio 
and MUFA intake is therefore likely false due to MUFA’s rela-
tionship with SFA intake and SFA’s significant positive asso-
ciation with the [Kyn]:[Trp] ratio.
To further establish the associations we found between FA 
intake and the [Kyn]:[Trp] ratio we subsequently quantified 
the percentage of FA in the membrane of RBC from this same 
cohort. Again to our surprise statistical analysis revealed a sig-
nificant inverse association between the [Kyn]:[Trp] ratio and 
the percentage of Total SFA incorporated into the membrane. 
More specifically an increase in the [Kyn]:[Trp] ratio was sig-
nificantly associated with a reduction in the percentage of 
Stearic acid and non-significantly associated with a reduc-
tion in the percentage of Palmitic as well as Arachidic acid. 
Contrariwise the [Kyn]:[Trp] ratio was positively associated 
with the percentage of both Total MUFAs as well as the per-
centage of Palmitoleic and Oleic acid.
Considering this data, the positive association we observed 
between membrane SFAs and their first or second MUFA 
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derivative, as well as the known influence of SFAs and MUFAs 
on inflammatory activity, we hypothesised that these observa-
tions may be due to an increase in the activity of Δ9 desaturase 
(also called Stearoyl-CoA 9-desaturase). Δ9 desaturase is the 
rate limiting enzyme responsible for the desaturation of both 
Palmitic and Stearic acid to Palmitoleic and Oleic acids respec-
tively (Figure 1).
Consistent with this hypothesis, the activity of Δ9 desatu-
rase was positively associated with the [Kyn]:[Trp] ratio. Δ9 
desaturase activity also tended to rise alongside increases in 
TNF-α. Importantly TNF-α has been shown to transcription-
ally enhance IFN-γ induced IDO expression,28 thus facilitat-
ing the catabolism of Trp to Kyn. In accordance with this we 
also observed a parallel, though not statistically significant, rise 
in [TNF-α] alongside the [Kyn]:[Trp] ratio. Others have simi-
larly reported positive associations between Δ9 desaturase 
activity and both circulating SFAs and inflammatory markers 
in humans.29
Thus considered as a whole, the data suggests that stimula-
tion of innate immune pro-inflammatory processes, in response 
to chronic SFA ingestion, upregulates Δ9 desaturase activity 
resulting in increased desaturation of SFA substrates (eg, Stearic 
and Palmitic acid) to their MUFA derivatives.30 This goes some 
way to explain the initially unexpected findings of an inverse 
correlation between [Kyn]:[Trp] and RBC membrane SFA’s 
and yet positive correlation between [Kyn]:[Trp] and the 
MUFAs, (being the corresponding SFA metabolites of Δ9 
desaturase activity). While lower SFA intake has demonstrated 
benefits,31 reduced membrane concentrations due to desatura-
tion may have an opposing effect.30 Indeed increased Δ9 desatu-
rase activity, expression or concentration, has previously been 
associated with several disease states including Alzheimer’s 
disease,32 diabetes,33 and some forms of cancer.34,35 The high 
degree of Δ9 desaturase regulation indicates that maintaining 
cellular lipid homeostasis is likely vital for a variety of cellular 
processes, with either too much or too little saturated or mono-
unsaturated FAs having detrimental consequences.36-39
This study did have a number of limitations. While the 
method of estimating Δ9 desaturase activity in cell membranes 
was sound, and previously used by others,40 we did not directly 
quantify Δ9 desaturase activity. As such the present results for 
Δ9 desaturase activity should be interpreted with caution pend-
ing future confirmation using direct measurements. Similarly 
while the [Kyn]:[Try] ratio is commonly used as a surrogate 
indicator of INF-γ induced IDO activity, both INF-γ and 
IDO activity were not directly measured. A number of the 
reported observations also did not quite reach statistical sig-
nificance. However none of these observations were solely 
relied upon in the formation of assumptions or conclusions, 
and only reported as a ‘trend’ when the effect size was appropri-
ately robust. Future studies involving a larger number of par-
ticipants that directly quantitates levels of INF-γ and both Δ9 
desaturase and IDO activity should however be performed to 
confirm our findings. Investigations using cell culture and/or 
animal models should also be undertaken to elucidate the 
mechanisms involved.
Despite these limitations, a number of conclusions can be 
reliably drawn from this study. The data confirms reports by 
others of a parallel rise in inflammation alongside chronic SFA 
consumption, even in healthy humans. A unique finding from 
this data was that SFA intake increases kynurenine production 
from tryptophan, most likely through stimulation of IDO 
activity via INF-γ mediated pathways. In addition, while await-
ing confirmation with direct testing, our data suggest that SFA 
Figure 1. Fatty acids synthesis.
Increased ingestion of saturated fatty acids, in particular Palmitic acid (C16:0) and Stearic acid (C18:0) may cause upregulation of delta 9 desaturase (Δ9) via an 
increase in indoleamine 2,3 dioxygenase (IDO) mediated inflammation. This may result in increased conversion of saturated fatty acids to their monounstaured derivate. 
Fatty acid structures derived from PubChem.
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linked increases in inflammation occur concomitantly with an 
upregulation of Δ9 desaturase activity resulting in increased 
desaturation of SFA substrates to their MUFA derivatives. 
Due to the role of inflammation in the development and pro-
gression of several disease states we hope these findings can 
increase the awareness of health professionals to the probability 
that SFA consumption will accelerate tryptophan catabolism 
via the kynurenine pathway creating a range of negative health 
sequelae.41
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